Citation: | Xueying Wang, Zhongjun Li. Comment on "An enzymatic pathway in the human gut microbiome that converts A to universal O type blood"[1][J]. Blood&Genomics, 2021, 5(2): 147-148. doi: 10.46701/BG.2021022021122 |
[1] |
Rahfeld P, Sim L, Moon H, et al. An enzymatic pathway in the human gut microbiome that converts A to universal O type blood[J]. Nature Microbiology, 2019, 4(9): 1475−1485. doi: 10.1038/s41564-019-0469-7
|
[2] |
Goldstein J, Siviglia G, Hurst R, et al. Group B erythrocytes enzymatically converted to group O survive normally in A, B, and O individuals[J]. Science, 1982, 215(4529): 168–170.
|
[3] |
Liu QP, Yuan H, Bennett EP, et al. Identification of a GH110 subfamily of alpha 1, 3-galactosidases: novel enzymes for removal of the alpha 3Gal xenotransplantation antigen[J]. J Biol Chem, 2008, 283(13): 8545–8554.
|
[4] |
Fernandes HP, Cesar CL, Barjas-Castro Mde L. Electrical properties of the red blood cell membrane and immunohematological investigation[J]. Rev Bras Hematol Hemoter, 2011, 33(4): 297−301. doi: 10.5581/1516-8484.20110080
|
[5] |
Rahfeld P, Withers SG. Toward universal donor blood: Enzymatic conversion of A and B to O type[J]. J Biol Chem, 2020, 295(2): 325–334.
|
[6] |
Provan D, Arnold DM, Bussel JB, et al. Updated international consensus report on the investigation and management of primary immune thrombocytopenia[J]. Blood Adv, 2019, 3(22): 3780–3817.
|
[7] |
Blumberg N, Masel D, Mayer T, et al. Removal of HLA-A, B antigens from platelets[J]. Blood, 1984, 63(2): 448–450.
|